CYP3A7 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of CYP3A7 monoclonal antibodies for research focused on understanding CYP3A7 protein function. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CYP3A7 is a member of the cytochrome P450 superfamily, which is crucial for the metabolism of various endogenous and exogenous compounds. CYP3A7 plays a significant role in drug metabolism and the biotransformation of steroids, making it essential for pharmacokinetics and toxicology studies. Understanding CYP3A7 function provides insights into developmental pharmacology and the metabolic processes that occur during fetal development. Researchers worldwide rely on CYP3A7 monoclonal antibodies to advance their studies in drug metabolism and development. The specificity and reliability of CYP3A7 monoclonal antibodies enable precise detection and characterization of metabolic pathways. Santa Cruz Biotechnology monoclonal antibodies for CYP3A7 continue to support breakthrough discoveries in developmental biology and drug metabolism research.